FMR »

Aardvark Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by FMR from 13F filings

Historical chart of FMR investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2026-06-30 $109k 19k 5.76
2026-03-31 $34k 9.0k 3.77
2025-12-31 $17k 1.3k 13.13
2025-09-30 $4.8k 363 13.29

More positions owned by FMR

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ge Vernova (GEV)
Exxon Mobil Corporation (XOM)
Ge Aerospace Com New (GE)

View all positions for FMR

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Capital Management
AQR Capital Management
EcoR1 Capital
Adage Capital Partners GP
State Street Corporation
BlackRock
Geode Capital Management
Cantor Fitzgerald, L. P.
Two Sigma Investments
Raymond James Financial
Vanguard Fiduciary Trust
Woodline Partners

View all funds holding Aardvark Therapeutics